Combo: A Combination of Sirolimus-Eluting Biodegradable Polymer and Anti-CD34 Antibody Coated Stent - Mitchell Krucoff, MD, FSCAI

↳ This is a section part of Moment: CRT 2016 Technology & Innovation - Biodegradable Polymer DES Programs

Add this Moment to your Passport

Learn from this moment and keep it forever.

Add To Passport

$5.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Combo: A Combination of Sirolimus-Eluting Biodegradable Polymer and Anti-CD34 Antibody Coated Stent presented byMitchell Krucoff, MD, FSCAI at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.

Add To Passport

$5.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

Interventional Cardiologists
Interventional Fellows

Session Name: Biodegradable Polymer DES Programs

Track: Technology & Innovation

Learning Objectives

Update in advances with bioresorbable & DCB technologies in interventional procedures

Other Components in this Moment

Overview

Do the Clinical Data Support the Use of DES with Biodegradable Polymers over DES with Durable Polymers? - Robert Byrne, MB BCh, PhD

Everolimus-Eluting Bioabsorbable-Polymer DES Outcomes: SYNERGY Update - Dean Kereiakes, MD, FACC, FSCAI

EXCELLA Novolimus Elution from PLLA Polymer-Coated Stents - Stefan Verheye, MD, PhD

Orsiro: PLLA/Sirolimus Biodegradable: The BIOFLOW Studies Indepth - Thomas Pilgrim, MD

Combo: A Combination of Sirolimus-Eluting Biodegradable Polymer and Anti-CD34 Antibody Coated Stent - Mitchell Krucoff, MD, FSCAI

Emerging Programs of DES with Biodegradable Polymers - Ricardo Costa, PhD